References

10.3322/caac.21590

10.3322/caac.21590 · External reference

Unresolved reference

2016 · External reference

10.1001/jama.2018.19323

10.1001/jama.2018.19323 · External reference

10.1056/nejmoa052306

10.1056/nejmoa052306 · External reference

10.1056/nejmra1001389

10.1056/nejmra1001389 · External reference

10.1093/jnci/dju055

10.1093/jnci/dju055 · External reference

10.1177/1758835918786451

10.1177/1758835918786451 · External reference

10.1056/nejmoa1706450

10.1056/nejmoa1706450 · External reference

10.15761/icst.1000228

10.15761/icst.1000228 · External reference

Multigene prognostic tests in breast cancer: past, present, future

10.1186/s13058-015-0514-2 · 2015 · External reference

Estrogen receptor: a prognostic factor in breast cancer

10.1002/1097-0142(19810201)47:3<554::aid-cncr2820470322>3.0.co;2-w · 1981 · External reference

10.1126/science.3798106

10.1126/science.3798106 · External reference

Evaluation of microarray preprocessing algorithms based on concordance with RT-PCR in clinical samples

10.1371/journal.pone.0005645 · 2009 · External reference

Meta-analysis of gene expression profiles associated with histological classification and survival in 829 ovarian cancer samples

10.1002/ijc.26364 · 2012 · External reference

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

10.1093/annonc/mdt303 · 2013 · External reference

Improving pathological assessment of breast cancer by employing array-based transcriptome analysis

10.3390/microarrays2030228 · 2013 · External reference

10.1038/nprot.2008.211

10.1038/nprot.2008.211 · External reference

10.1007/s10549-009-0674-9

10.1007/s10549-009-0674-9 · External reference

Jetset: selecting the optimal microarray probe set to represent a gene

10.1186/1471-2105-12-474 · 2011 · External reference

10.1016/s0140-6736(11)61625-5

10.1016/s0140-6736(11)61625-5 · External reference

Principles of cancer treatment by chemotherapy

10.1016/j.mpsur.2017.12.002 · 2018 · External reference

Patient-reported cognitive impairment among women with early breast cancer randomly assigned to endocrine therapy alone versus chemoendocrine therapy: results from TAILORx

10.1200/jco.19.01866 · 2020 · External reference

A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer

10.1007/s10549-013-2622-y · 2013 · External reference

Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer

10.1056/nejmoa1904819 · 2019 · External reference

10.1056/nejmoa1804710

10.1056/nejmoa1804710 · External reference

EndoPredict® in early hormone receptor-positive, HER2-negative breast cancer

10.1007/s10549-020-05688-1 · 2020 · External reference

10.1091/mbc.e10-04-0335

10.1091/mbc.e10-04-0335 · External reference

10.2174/156652412798376134

10.2174/156652412798376134 · External reference

10.1200/jco.2009.27.2419

10.1200/jco.2009.27.2419 · External reference

10.1371/journal.pone.0157368

10.1371/journal.pone.0157368 · External reference

10.1158/1078-0432.ccr-15-1315

10.1158/1078-0432.ccr-15-1315 · External reference

10.1371/journal.pone.0030804

10.1371/journal.pone.0030804 · External reference

Tailoring therapies–improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

10.1093/annonc/mdv221 · 2015 · External reference

10.1038/nrc2789

10.1038/nrc2789 · External reference

10.18632/oncotarget.25495

10.18632/oncotarget.25495 · External reference

Association of independent prognostic factors and treatment modality with survival and recurrence outcomes in breast cancer

10.1001/jamanetworkopen.2020.7213 · 2020 · External reference

10.1038/sj.bjc.6605478

10.1038/sj.bjc.6605478 · External reference

MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer

10.1186/1471-2407-14-837 · 2014 · External reference